Stay updated on Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A newer last update date and verification timestamps appear in Study Record Dates, while core study details (status, enrollment, eligibility, and procedures) remain unchanged.
    Difference
    0.3%
    Check dated 2025-10-27T20:55:26.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now includes a government-operating status notice and a new resource topic, bumps the revision to v3.2.0, and removes the old v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T08:11:45.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Updated page to version v3.1.0 and removed the topic 'Diffuse large B-cell lymphoma' from resources; this indicates a targeted removal of a specific disease topic from core content.
    Difference
    0.4%
    Check dated 2025-09-29T04:41:04.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2 (replacing v3.0.1); Back to Top link removed.
    Difference
    0.1%
    Check dated 2025-09-14T22:14:28.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:33:29.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has added significant drug information, including new drugs and resources related to genetic and rare diseases, while removing several previous entries related to drug classifications and specific diseases.
    Difference
    7%
    Check dated 2025-08-31T12:28:41.000Z thumbnail image

Stay in the know with updates to Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.